panic webinar
panic webinar
Webinar

Oligonucleotide-based Therapeutics: NMR Techniques for Characterization

Webinar Overview

PANIC Spring Webinar

As the importance and number of Oligonucleotide therapeutics grows, so too does the need for characterization methodologies both during drug development and production. Because structure is so intricately entwined in therapeutic efficacy for this class of drug, detailed characterization of structure is critical. Nuclear Magnetic Resonance (NMR) can deliver detailed structural information that spans the breadth of the different oligonucleotide-base therapies being developed. This webinar will detail some of the latest advancements in NMR oligonucleotide-based drug characterization.

Tuesday, 12 March 2024, 11:00 ES

Presentations

  • The vital role of NMR in analyzing nucleic acids’ structure and dynamics for small molecule drug discovery advancements
    Celestine Chi, AstraZeneca
  • Multi-attribute assessment of anti-sense therapeutics
    Robert Brinson, IBBR, NIST
  • NMR of RNA and therapeutic oligonucleotides
    Martial Piotto, Bruker BioSpin

Key Learning Topics

  • Different approaches to the characterization of oligonucleotide therapeutic with NMR
  • Pharmaceutical trends and requirements for oligonucleotide-based therapeutics
  • Latest developments from Bruker to address requirements in characterization of oligonucleotide and other macromolecular therapeutics.

Speakers

Celestine Chi

Biophysics, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden

Dr. Celestine Chi is a distinguished researcher with expertise in the realm of molecular sciences. He received his Ph.D. from Uppsala University, Sweden with Prof. Per Jemth, delving deeply into the intricacies of protein folding and binding. Celestine then pursued a postdoctoral position at ETH, Zurich with Prof. Roland Riek. He returned to Uppsala University before moving onto industry. Celestine currently serves as an NMR specialist and Senior Scientist at AstraZeneca in Gothenburg, Sweden, focusing on unlocking the enigmatic world of non-coding genomes, unravelling structural dynamics and pioneering novel methodologies to target these entities with precision using small molecules.

Robert Brinson

Research Chemist in the Biomolecular Structure and Function Group at the Institute for Bioscience and Biotechnology Research (IBBR), a joint research institute of the University of Maryland and NIST, in Rockville, Maryland

Robert applies biophysical measurements to define structure and dynamics of nucleic acids, proteins, and glycoproteins. Robert seeks to push the limits of NMR methodologies to define the critical quality attribute of higher order structure for drug substances. He received his Ph.D. in chemistry from Wake Forest University, then entered the field of structural biology as a NIH/NIST NRC postdoctoral fellow under John Marino (NIST) and Stuart Le Grice (NCI). Under their direction, Robert performed high resolution NMR studies on important nucleic acid elements from various viruses.

Dr. Martial Piotto

Pharma product manager of Biologics solutions

Martial Piotto obtained his Ph.D. in NMR spectroscopy at the University of Purdue, USA (Pr. D. Gorenstein). He then joined Bruker France as head of NMR application where he worked on various aspects of NMR spectroscopy, notably the development of new pulse sequences and HRMAS technology. Over the years, he grew an interest in applications of NMR in the pharmaceutical and medical fields. His work currently focusses on the characterization of Biologics (mAb, vaccines and therapeutic oligonucleotides) by combining NMR and multivariate statistical tools.

Registration

Input value is invalid.

Are you already in contact with your Bruker representative regarding any product inquiries?

We constantly want to improve our service for our customers. In answering the following question you help us to serve your needs even better in the future: What best describes your situation?

By ticking this box, I agree to receive, from time to time, emails from Bruker and its affiliates within the Bruker Group on upcoming events, webinars, our products and services, surveys and Bruker's corporate news.
I can unsubscribe at any time, by contacting Bruker or clicking on the opt-out link in the email if available. For more information on the processing of your personal data, please check Bruker’s Privacy Policy. 

By submitting this form I agree my personal data will be used to process my registration to the webinar. I have read and accepted the Bruker Website Privacy Notice (https://www.bruker.com/privacy-policy.html) and I agree to the Terms of Use (https://www.bruker.com/terms-of-use.html) of the Bruker website.

Already registered and lost your invitation link?

Thank you. The invitation link has been resent.